The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells.
about
Analysis of nucleocytoplasmic trafficking of the HuR ligand APRIL and its influence on CD83 expressionCD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cellsTolerance in liver transplantation: Biomarkers and clinical relevanceThe Polyunsaturated Fatty Acids Arachidonic Acid and Docosahexaenoic Acid Induce Mouse Dendritic Cells Maturation but Reduce T-Cell Responses In VitroCD83 modulates B cell function in vitro: increased IL-10 and reduced Ig secretion by CD83Tg B cells.A Kinetic Study of CD83 Reveals an Upregulation and Higher Production of sCD83 in Lymphocytes from Pregnant MiceAlcohol exposure impairs myeloid dendritic cell function in rhesus macaques.CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation.Association of Neisseria gonorrhoeae Opa(CEA) with dendritic cells suppresses their ability to elicit an HIV-1-specific T cell memory responseCell adhesion and polarity during immune interactions.Dendritic cell CD83 homotypic interactions regulate inflammation and promote mucosal homeostasisThe expression and characterization of functionally active soluble CD83 by Pichia pastoris using high-density fermentation.Dendritic cell-based immunotherapy for the treatment of hematological malignancies.CD83-stimulated monocytes suppress T-cell immune responses through production of prostaglandin E2.Human T-cell leukemia virus type-I Tax induces the expression of CD83 on T cells.Dysfunctional DC subsets in RCC patients: ex vivo correction to yield an effective anti-cancer vaccinePrevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83Viruses and dendritic cells: enemy mine.The CD83 reporter mouse elucidates the activity of the CD83 promoter in B, T, and dendritic cell populations in vivo.Dendritic cell CD83: a therapeutic target or innocent bystander?Th-1 polarization is regulated by dendritic-cell comparison of MHC class I and class II antigens.Thymic CD4 T cell selection requires attenuation of March8-mediated MHCII turnover in cortical epithelial cells through CD83.Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14+ Monocytes.Plasmodium falciparum-infected erythrocytes and beta-hematin induce partial maturation of human dendritic cells and increase their migratory ability in response to lymphoid chemokines.Triple costimulation via CD80, 4-1BB, and CD83 ligand elicits the long-term growth of Vγ9Vδ2 T cells in low levels of IL-2.Honokiol inhibits LPS-induced maturation and inflammatory response of human monocyte-derived dendritic cells.Enhanced activation of CD83-positive T cells.Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus.Multiple interferon regulatory factor and NF-κB sites cooperate in mediating cell-type- and maturation-specific activation of the human CD83 promoter in dendritic cells.Phosphorylation of the HuR ligand APRIL by casein kinase 2 regulates CD83 expression.Herpes simplex virus type 1 induces CD83 degradation in mature dendritic cells with immediate-early kinetics via the cellular proteasome.Sex Bias in Pathogenesis of Autoimmune Neuroinflammation: Relevance for Dimethyl Fumarate Immunomodulatory/Anti-oxidant Action.Expression of CD83 is regulated by HuR via a novel cis-active coding region RNA element.The Major Immediate-Early Protein IE2 of Human Cytomegalovirus Is Sufficient to Induce Proteasomal Degradation of CD83 on Mature Dendritic CellsThe Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population.CD83 Modulates B Cell Activation and Germinal Center Responses.Post-transcriptional regulation of CD83 expression by AUF1 proteinsEngagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity.Soluble CD14 and CD83 from human neonatal antigen-presenting cells are inducible by commensal bacteria and suppress allergen-induced human neonatal Th2 differentiation.Targeting CD83 for the treatment of graft-versus-host disease.
P2860
Q24337293-20DEE79E-2BF6-400B-AD5D-4203445349EBQ24528149-62C0BC17-B767-40EE-9072-6B644EA89CFAQ28079523-9C39E5E1-174C-460C-B51B-60DE4DFFF59BQ28395094-02982368-842D-40BD-B605-3FE95842D86CQ33294726-50352708-C9F4-4618-8288-DCC6E3F6F856Q33603244-2B568F2B-47DC-4797-979C-8100E01A77F5Q34167130-46A05F0C-2B4B-4EE8-80D4-E99C59733FC6Q34501441-F29F4C85-7E9C-463D-8E84-66775B3788E5Q34592903-7EFC08F0-246A-48D5-93D2-048162E5AEA0Q34862177-0F4086DF-5F49-4D89-AAF2-F50F5D82392EQ35080739-C49D9F3D-A7B6-4CF4-ADE4-3F010AEBDA6DQ35106954-F068C453-97B9-42EE-B8A6-F8CA0AE2C11CQ35127001-B15ADE36-00F5-4C93-A8D2-E00A0F5581BDQ35558734-672214EC-662D-4CF2-9F5F-EED5EE9E478AQ35806714-640A516A-C5D3-4C17-B078-BAF4F9E50330Q36190058-41EB3CC2-791A-4951-B91C-0ADF70CA8F9CQ36399744-AFABF46E-E03B-4CFF-8CCA-A022D46557EAQ36729667-2DABD298-F9F2-4AE9-BE25-3A9BBBB29D36Q36836259-0EF38B60-D3E6-4726-93DE-9E811AC69E9CQ37000947-5DBB23A6-9240-41E3-9F23-1A7EFB8E475AQ37176537-621D4484-9ED1-40B8-B192-E3168F833B7DQ37197974-0B7E9A0A-35B1-4AB9-BD24-9196D89D2211Q37681536-F34E1654-2304-4F73-9B4A-3CF5C08C7B13Q38686772-F988D984-BCF8-4E33-B764-6BDAE47DAC1BQ38819970-FAE7D902-30F8-4C1F-B239-B420D6E5B873Q39527075-51C50F3B-B0B0-4EB4-BCDB-716597DC37BBQ39600056-BCE35E83-E73B-49D0-AF3C-5EE00129C279Q39787577-67464212-5D62-4BEB-ADBB-539A62EAD22FQ39790735-2C7DF81C-15AB-41A3-B2AB-A6AEA70BDF37Q39897656-B978FA19-8666-41AC-B213-8E325A5930BCQ40146699-913D1F36-F8A1-41BB-9257-77E30B5EE78AQ40189763-F902DBA7-A509-4C7A-B493-D73921DC1A9FQ40315202-6AF24294-5245-4282-8C1F-3833C21F6A16Q40331128-7A12CD09-E4B2-444D-B94D-DAF28AD05778Q40478640-FAA33938-786E-4138-AA21-DDBB490241E5Q40752721-D20EBB13-F178-4268-B4BB-FA5AA26C9748Q41431895-7A88BA26-8B64-40A8-BD70-987E3BB92AB1Q41843310-73863AD0-0055-4FE2-8A3C-C399F49D1CC6Q41872741-4FB042E9-E3B5-4859-9A5B-D55EFE17F1BCQ43104684-A002D96D-D83F-4DC6-8E15-B0670A0A16F7
P2860
The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
The extracellular domain of CD ...... o a ligand on dendritic cells.
@en
The extracellular domain of CD ...... o a ligand on dendritic cells.
@nl
type
label
The extracellular domain of CD ...... o a ligand on dendritic cells.
@en
The extracellular domain of CD ...... o a ligand on dendritic cells.
@nl
prefLabel
The extracellular domain of CD ...... o a ligand on dendritic cells.
@en
The extracellular domain of CD ...... o a ligand on dendritic cells.
@nl
P2093
P2860
P356
P1476
The extracellular domain of CD ...... to a ligand on dendritic cells
@en
P2093
A Steinkasserer
D J Krooshoop
M Lechmann
P2860
P304
P356
10.1084/JEM.194.12.1813
P407
P577
2001-12-01T00:00:00Z